Our aim, therefore, was to investigate the role of various metabolic parameters, including those of tumour burden, measured using pre-operative [18F]FDG-PET/CT, in predicting PD-L1 expression of primary tumour and nodal metastases in patients with resectable NSCLC. The gene discussed is CD274; the disease is non-small cell lung carcinoma.